Prelude Capital Management’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $962K | Sell |
18,156
-44
| -0.2% | -$2.33K | 0.09% | 268 |
|
|
2025
Q1 | $903K | Buy |
18,200
+44
| +0.2% | +$2.18K | 0.07% | 279 |
|
|
2024
Q4 | $1.15M | Buy |
18,156
+4,156
| +30% | +$263K | 0.07% | 284 |
|
|
2024
Q3 | $688K | Buy |
14,000
+400
| +3% | +$19.7K | 0.04% | 445 |
|
|
2024
Q2 | $613K | Buy |
13,600
+10,100
| +289% | +$455K | 0.04% | 399 |
|
|
2024
Q1 | $218K | Buy |
+3,500
| New | +$218K | 0.01% | 957 |
|
|
2022
Q3 | – | Sell |
-1,037
| Closed | -$53K | – | 1618 |
|
|
2022
Q2 | $53K | Sell |
1,037
-2
| -0.2% | -$102 | ﹤0.01% | 1254 |
|
|
2022
Q1 | $43K | Sell |
1,039
-54
| -5% | -$2.24K | ﹤0.01% | 1203 |
|
|
2021
Q4 | $95K | Buy |
+1,093
| New | +$95K | ﹤0.01% | 1367 |
|